Raphael Schiffmann (R Schiffmann)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 12

Top Topics

Helicobacter Pylori

Top Venues

Advances in therapy

Journal of inherited metabolic disease

Brain : a journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Raphael Schiffmann, Karl Eugen Mengel, Mary Wallace, Camille Rochmann, James Turnbull, Robert Krupnick, Chad Gwaltney, Ruth Pulikottil-Jacob, Isabela Batsu, Riliang Zheng, Alaa Hamed
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP). Advances in therapy (2024)
Raphael Schiffmann, Karl Eugen Mengel, Mary Wallace, Camille Rochmann, James Turnbull, Robert Krupnick, Chad Gwaltney, Ruth Pulikottil-Jacob, Isabela Batsu, Riliang Zheng, Alaa Hamed
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP). Advances in therapy 41 (7) (2024)
Raphael Schiffmann, Karl Eugen Mengel, Mary Wallace, Camille Rochmann, James Turnbull, Robert Krupnick, Chad Gwaltney, Ruth Pulikottil-Jacob, Isabela Batsu, Riliang Zheng, Alaa Hamed
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP). Advances in therapy 41 (7) (2024)
Raphael Schiffmann, Karl Eugen Mengel, Mary Wallace, Camille Rochmann, James Turnbull, Robert Krupnick, Chad Gwaltney, Ruth Pulikottil-Jacob, Isabela Batsu, Riliang Zheng, Alaa Hamed
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP). Advances in therapy 41 (7) (2024)
Raphael Schiffmann, Karl Eugen Mengel, Mary Wallace, Camille Rochmann, James Turnbull, Robert Krupnick, Chad Gwaltney, Ruth Pulikottil-Jacob, Isabela Batsu, Riliang Zheng, Alaa Hamed
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP). Advances in therapy 41 (7) (2024)
Raphael Schiffmann, Karl Eugen Mengel, Mary Wallace, Camille Rochmann, James Turnbull, Robert Krupnick, Chad Gwaltney, Ruth Pulikottil-Jacob, Isabela Batsu, Riliang Zheng, Alaa Hamed
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP). Advances in therapy 41 (7) (2024)
Paulina Dabrowska-Schlepp, Andreas Busch, Jin-Song Shen, Rachel Y Cheong, Lone Bruhn Madsen, Daniel Mascher, Raphael Schiffmann, Andreas Schaaf
Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry disease. JIMD reports 64 (6) (2023)
Raphael Schiffmann, Timothy M Cox, Jean-François Dedieu, Sebastiaan J M Gaemers, Julia B Hennermann, Hiroyuki Ida, Karl Eugen Mengel, Pascal Minini, Pramod Mistry, Petra B Musholt, David Scott, Jyoti Sharma, M Judith Peterschmitt
Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial. Brain : a journal of neurology (2022)
Daniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, Hiroki Maruyama, Atul B Mehta, Nina Skuban, Eva Krusinska, Raphael Schiffmann
Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease. Genetics in medicine : official journal of the American College of Medical Genetics 23 (1) (2020)
Raphael Schiffmann, Jeff Sevigny, Arndt Rolfs, Elin Haf Davies, Ozlem Goker-Alpan, Magy Abdelwahab, Ashok Vellodi, Eugen Mengel, Elena Lukina, Han-Wook Yoo, Tanya Collin-Histed, Aya Narita, Tama Dinur, Shoshana Revel-Vilk, David Arkadir, Jeff Szer, Michael Wajnrajch, Uma Ramaswami, Ellen Sidransky, Aimee Donald, Ari Zimran
The definition of neuronopathic Gaucher disease. Journal of inherited metabolic disease 43 (5) (2020)
L Saint-Val, Thomas Courtin, Perrine Charles, C Verny, Martin Catala, Raphael Schiffmann, Odile Boespflug-Tanguy, Fanny Mochel
GJA1 Variants Cause Spastic Paraplegia Associated with Cerebral Hypomyelination. AJNR. American journal of neuroradiology 40 (5) (2019)
Raphael Schiffmann
A genetic form of achlorhydria and gastritis. The American journal of clinical nutrition 102 (6) (2016)